ConductScience.org, home

Library / Genes

HLA-DQB1: major histocompatibility complex, class II, DQ beta 1

1 protein, 42 patents, 0 drugs, 0 trials, 5,211 NIH grants and 13,659 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolHLA-DQB1HGNC
Namemajor histocompatibility complex, class II, DQ beta 1HGNC
NCBI Gene ID3119NCBI Gene
HGNC IDHGNC:4944HGNC
EnsemblENSG00000179344NCBI Gene
AliasesCELIAC1, HLA-DQB, IDDM1NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P01920HLA class II histocompatibility antigen, DQ beta 1 chain26110GeneID, HGNCUniProt

Patents 42

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4801948 A12026-09-0941P01920Espacenet
JP 2026501516 A2026-01-1623869P01920Espacenet
JP 2026004568 A2026-01-1452404P01920Espacenet
JP 2026004568 A2026-01-1452406P01920Espacenet
EP 4646428 A12025-11-1223869P01920Espacenet
KR 1020250133399 A2025-09-0523869P01920Espacenet
JP 2025062601 A2025-04-1479P01920Espacenet
WO 2024252368 A22024-12-12239P01920Espacenet
JP 2024517658 A2024-04-2376P01920Espacenet
JP 2024516610 A2024-04-1676P01920Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 5211

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P01CA018029Adult Leukemia Research Center812,025NIH's project files
P30CA015704Cancer Center Support Grant592,025NIH's project files
U24CA076518A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research592,025NIH's project files
R01DK032083Multiple Autoantigens, Multiple Epitopes of Type 1 Diabetes512,025NIH's project files
P30CA008748Cancer Center Support Grant482,025NIH's project files
P30CA016672Cancer Center Support Grant432,025NIH's project files
P30DK017047Diabetes Research Center402,025NIH's project files
U01AI069197Hematopoietic Stem Cell And Cord Blood Transplantation292,025NIH's project files
P01CA078902Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge282,025NIH's project files
R01CA100019Clinical Significance of MHC Haplotypes in HCT282,025NIH's project files

Papers 13659

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42827347PubTator, text miningPubMed
42825917PubTator, text miningPubMed
42812615PubTator, text miningPubMed
42808844PubTator, text miningPubMed
42808837PubTator, text miningPubMed
42808222PubTator, text miningPubMed
42806292PubTator, text miningPubMed
42805113PubTator, text miningPubMed
42802482PubTator, text miningPubMed
42802421PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license